Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-09

Clinical Trial Update: Effects of the TNF-alpha Inhibiton on Hemodynamic Parameters in Resistant Hypertension [Phase 4]

View source ↗

Summary

This update reports on the effects of TNF-alpha inhibition on hemodynamic parameters in patients with resistant hypertension in Phase 4.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Campinas, Brazil | Conditions: Hypertension | Phase 4 | Status: COMPLETED